Is DHR a good stock to buy?
Danaher Corporation · end-of-day data as of Nov 13, 2026
- ConsensusBuy · 24
- Trendbullish
- MAs4 of 4
- Sector▲ +15.9%
- Earnings in75d
- P/E38.1x
- RSI55
- Support-1.0%
- Resistance+2.4%
- Off 52w high-4.0%
- Volume0.8x
- Bollingerupper half
- News0.00
- FCF yield+3.5%
- P/E vs own+0.3%
- PT$243.63 +4.6%
- 52w range$161–$243
- ATR+2.7%
- Off ATH-21.3%
- P/E vs sector+18.4%
- Insiders-$26.11M
- MACD-0.43
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is Danaher a good stock to buy?
Danaher is strong on 2 of the 4 questions about the business; weak on demand. The price is about usual: 38.1 times its earnings, near its 3-year median of 41.1 (Nov 13, 2026). pretickt does not say whether to buy or sell.
DHR sales growth revenue growth
-7%a year, for the last 3 yearsDanaher's sales fell 7% a year for 3 years, to $24.57B in fiscal 2025.
DHR analysts' forecast revenue estimates
+7%the sales they expect next fiscal year, on the lastAnalysts expect Danaher's sales to grow 7% to $26.26B in fiscal 2026 (16 analysts).
DHR competitors
pretickt analysis+6%its sales in 12 months, on a year before
Danaher's sales grew 6% in the 12 months to Sep 25, 2026, slower than Natera (+37%), Idexx Laboratories (+12%), Agilent (+9%) and Thermo Fisher (+8%).
DHR sales by business revenue by segment
82%of its sales from Revenue from Contract with Customer, Measurement, RecurringRevenue from Contract with Customer, Measurement, Recurring brought Danaher 82% of its sales in fiscal 2025; Revenue from Contract with Customer, Measurement, Nonrecurring 18%.
DHR cash generated free cash flow
$5.73Bcash left after investing, last 12 monthsDanaher generated $5.73B of free cash flow in the 12 months to Sep 25, 2026, more than its reported profit.
DHR earnings vs estimates
7 of 8quarters above the analysts' estimateDanaher beat the analysts' profit estimate in 7 of its last 8 quarters, the latest on Oct 21, 2026.
DHR insider selling
-$36.73Msold, net, by its executives in 12 monthsDanaher's executives and directors sold a net $36.73M of shares in the 12 months to Nov 13, 2026; none bought.
DHR number of employees
-5%fewer people in a yearDanaher had 60,000 employees at the end of fiscal 2025, 5% fewer than a year before.
DHR CEO pay
$20.9Mfor fiscal 2023, 75% of it in stock and optionsDanaher paid its CEO $20.9M for fiscal 2023, 75% of it in stock and options.
DHR financial health Altman Z-score
3.7Altman Z-score, safe above 3Danaher's Altman Z-score is 3.7 (Nov 13, 2026), above 3, where the safe zone starts.
DHR quality checks Piotroski score
6 of 9checks passedDanaher passes 6 of the 9 Piotroski checks in the 12 months to Sep 25, 2026; it misses on long-term debt, gross margin and sales for its assets.
DHR price vs profit P/E ratio
38.1×a year's earningsDanaher's P/E ratio is 38.1 (Nov 13, 2026), near its 3-year median of 41.1.
DHR price vs competitors
pretickt analysis38.1×a year's earnings, against its competitorsInvestors pay 38.1 times Danaher's earnings (Nov 13, 2026), more than for Thermo Fisher (36.9) and Agilent (34.2), less than for Idexx Laboratories (47.8).
DHR analysts' target price target
+5%to their average targetAnalysts' average price target for Danaher is $244, 5% above the Nov 13, 2026 close of $233.02.
DHR growth priced in fair value
pretickt analysis+12%a year, for ten years, to be worth the priceAt $233.02 a share, Danaher's free cash flow must grow about 12% a year for ten years to be worth the price (Nov 13, 2026).
What is Danaher's P/E ratio?
Danaher's P/E ratio is 38.1 (Nov 13, 2026), near its 3-year median of 41.1. Investors pay 38.1 times Danaher's earnings (Nov 13, 2026), more than for Thermo Fisher (36.9) and Agilent (34.2), less than for Idexx Laboratories (47.8).
Who are Danaher's biggest competitors?
pretickt compares Danaher with Thermo Fisher, Idexx Laboratories, Agilent and Natera. Danaher's sales grew 6% in the 12 months to Sep 25, 2026, slower than Natera (+37%), Idexx Laboratories (+12%), Agilent (+9%) and Thermo Fisher (+8%).
Are insiders selling Danaher stock?
Danaher's executives and directors sold a net $36.73M of shares in the 12 months to Nov 13, 2026; none bought.
How does Danaher make money?
Revenue from Contract with Customer, Measurement, Recurring brought Danaher 82% of its sales in fiscal 2025; Revenue from Contract with Customer, Measurement, Nonrecurring 18%.
Who owns Danaher stock?
2,196 institutions hold 83% of Danaher's shares (Jun 30, 2026); Vanguard, BlackRock and Fidelity added shares that quarter.
How many employees does Danaher have?
Danaher had 60,000 employees at the end of fiscal 2025, 5% fewer than a year before.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.